W U Primrose

Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase.

H P Driessen, L Y Lian, G C Roberts, 1996, Journal of structural biology.

Design and synthesis of some substrate analogue inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex.

W U Primrose, G. Roberts, G. Roberts, 1992, Journal of medicinal chemistry.

A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.

W U Primrose, M. Sutcliffe, C. Wolf, 1996, Biochemistry.

13C NMR study of the ionizations within a trypsin-chloromethyl ketone inhibitor complex.

W U Primrose, A. Scott, N. Mackenzie, 1985, Biochemistry.

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase.

W U Primrose, M. Sutcliffe, C. Wolf, 1997, Biochemistry.

A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.

W U Primrose, M. Sutcliffe, L. Lian, 1997, Biochemistry.